Performance

CTNM -5.72%

Watchlist

Select an item

RETURNS	1D	YTD	1Y	5Y Ann.	Max DD	Sharpe	Div. Yield
CTNM	+8.19%	-9.89%	-5.72%	—	-59.70%	0.30	0.00%

Summary

CTNM at a glance

CTNM returned -5.72% over the past year. Its worst drop in that year was -59.70%, smaller than 13% of stocks on Redstone, and its Sharpe ratio of 0.30 beats 41% of stocks on Redstone. It pays no dividends.

Ranking

How CTNM ranks

Current Drawdown

-41.38%

Rolling Volatility

154.61%

Actions

Metrics

Risk Indicators

Alpha8.65%

Beta1.58x

Sharpe0.30

Sortino0.42

Omega1.06

Calmar-0.10

Martin1.17

Profile

About CTNM

Contineum Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the development of oral small-molecule therapies for neurological, inflammatory, and immunological conditions.

Sector: Health Care
Industry: Pharmaceutical Preparations
Market cap: $404M
Listed: Apr 2024
Employees: 51
Headquarters: San Diego, CA
Website: contineum-tx.com

Comparisons

CTNM: Contineum Therapeutics, Inc.

CTNM at a glance

How CTNM ranks

Current Drawdown

Rolling Volatility

About CTNM

Related comparisons